Evidence map›Paper›PMID 34253174›Full record

ArticleBMC neurology2021

Clinical features and outcome of Guillain-Barre syndrome in Saudi Arabia: a multicenter, retrospective study.

Mohammed H Alanazy, Sawsan S Bakry, Afnan Alqahtani, Norah S AlAkeel, Naael Alazwary, Afag M Osman, Rania A Mustafa, Talal M Al-Harbi, Sameeh O Abdulmana, Aimee C Amper and 10 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMC neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 1 country.

Mohammed H AlanazyDivision of Neurology, Department of Internal Medicine, King Saud University Medical City and College of Medicine, King Saud University, Riyadh, Saudi Arabia. mohalanazy@ksu.edu.sa.
Sawsan S BakryDivision of Neurology, Department of Internal Medicine, King Saud University Medical City and College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Afnan AlqahtaniDivision of Neurology, Department of Internal Medicine, King Saud University Medical City and College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Norah S AlAkeelCollege of Medicine, King Saud University, Riyadh, Saudi Arabia.
Naael AlazwaryDepartment of Medicine, Security Forces Hospital Program, Riyadh, Saudi Arabia.
Afag M OsmanDepartment of Neurology, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Rania A MustafaDepartment of Neurology, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Talal M Al-HarbiNeurology Department, Neuroscience Center, King Fahad Specialist Hospital-Dammam, Dammam, Saudi Arabia.
Sameeh O AbdulmanaNeurology Department, Neuroscience Center, King Fahad Specialist Hospital-Dammam, Dammam, Saudi Arabia.
Aimee C AmperNeurology Department, Neuroscience Center, King Fahad Specialist Hospital-Dammam, Dammam, Saudi Arabia.
Yousef AldughaythirNeurology Department, National Neuroscience Institute, King Fahad Medical City, Riyadh, Saudi Arabia.
Abdulrahman S AliNeurology Department, National Neuroscience Institute, King Fahad Medical City, Riyadh, Saudi Arabia.
Seraj MakkawiCollege of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
Alaa MaglanCollege of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
Loujen AlamoudiCollege of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
Feras AlsulaimanDepartment of Neurology, King Fahad Hospital of the University, Imam Abdulrhman Bin Faisal University, Dammam, Saudi Arabia.
Majed AlabdaliDepartment of Neurology, King Fahad Hospital of the University, Imam Abdulrhman Bin Faisal University, Dammam, Saudi Arabia.
Aysha A AlShareefInternal Medicine Department, Neurology Division, Neuromuscular Medicine Unit, Faculty of Medicine and King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Saudi Arabia.
Ahmad R AbuzinadahInternal Medicine Department, Neurology Division, Neuromuscular Medicine Unit, Faculty of Medicine and King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Saudi Arabia.
Ahmed K BamagaPediatric department, Neuromuscular Medicine Unit, Faculty of Medicine and King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Saudi Arabia.
King Saud University · SAKing Abdulaziz University · SAKing Fahad Specialist Hospital · SAKing Saud bin Abdulaziz University for Health Sciences · SAKing Fahd Hospital of the University · SAKing Fahd Medical City · SARiyadh Armed Forces Hospital · SASecurity Forces Hospital · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGuillain-Barre syndrome (GBS) is an inflammatory polyradiculoneuropathy characterized by rapidly evolving weakness and areflexia, reaching nadir within 4 weeks. Data on the characteristic of GBS in Saudi Arabia are limited. This study aimed to describe the clinical, electrophysiological, and laboratory characteristics and outcome of a multicenter cohort of patients with GBS.

methodsThis is a retrospective multicenter nationwide study. Patients who had GBS, identified through Brighton Criteria, between January 2015 and December 2019 were included. Data collected included demographics, clinical features, cerebrospinal fluid profile, reported electrophysiological patterns, treatment, and outcome. Reported GBS subtypes were compared using chi-square, Fisher's exact, or Mann-Whitney U tests, as appropriate.

resultsA total of 156 patients with GBS were included (men, 61.5%), with a median age of 38 (interquartile range, 26.25-53.5) years. The most commonly reported antecedent illnesses were upper respiratory tract infection (39.1%) and diarrhea (27.8%). All but two patients (98.7%) had weakness, 64.1% had sensory symptoms, 43.1% had facial diplegia, 33.8% had oropharyngeal weakness, 12.4% had ophthalmoplegia, and 26.3% needed mechanical ventilation. Cytoalbuminological dissociation was observed in 69.1% of the patients. GBS-specific therapy was administered in 96.8% of the patients, of whom 88.1% had intravenous immunoglobulin, and 11.9% had plasmapheresis. Approximately half of the patients were able to walk independently within 9 months after discharge, and a third regained the ability to walk independently thereafter. Death of one patient was caused by septicemia. Acute inflammatory demyelinating polyradiculoneuropathy was the most commonly reported GBS subtype (37.7%), followed by acute motor axonal neuropathy (29.5%), and acute motor-sensory axonal neuropathy (19.2%).

conclusionThe clinical and laboratory characteristics and outcome of GBS in the Arab population of Saudi Arabia are similar to the international cohorts. The overall prognosis is favorable.

Indexed as

AdolescentAdultAgedFemaleGuillain-Barre SyndromeHumansImmunoglobulins, IntravenousMaleMiddle AgedPlasmapheresisPrognosisRespiration, ArtificialRetrospective StudiesSaudi ArabiaTreatment OutcomeYoung AdultImmunoglobulins, IntravenousAcute inflammatory demyelinating polyradiculoneuropathyAcute motor axonal neuropathyAcute motor-sensory axonal neuropathyGuillain–Barre SyndromeIntravenous immunoglobulinSaudi Arabia

Identifiers

PMID34253174
PMCPMC8273933
OpenAlexW3178759333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.